A randomised controlled trial of cognitive remediation in psychosis

Active, not recruiting

• Conditions: Schizophrenia; Mental Health - Schizophrenia

• Registration Number: ACTRN12605000202662
• Lead Sponsor: Dr Anthony Harris

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Diagnosis of schizophrenia, cognitive deficit of > 1 SD below premorbid functioning, stable medication for 2 months, stable residence.

Exclusion Criteria

Mental retardation, non-english speaking, current substance abuse, significant head injury or neurological condition, ECT in past 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in cognitive deficits[At the end of treatment and at 15 weeks post treatment]

Secondary Outcome Measures

Name	Time	Method
Improvement in negative symptoms[At end of treatment and at 15 weeks post treatment.];Quality of life[At end of treatment and at 15 weeks post treatment.];Social function and self esteem[At end of treatment and at 15 weeks post treatment.]